Zdrowie i gospodarka · 16/02/2005
FDA Reopens Comment Period for Follow-On Protein Products
The FDA is extending the comment period for its notice on follow-on protein pharmaceutical products until March 16, 2005, in response to requests for an extension, allowing interested persons more time to submit comments on the development and approval of these products.